Search Results 211-220 of 17794 for Coagulate

1. A Study to Create a Registry of Non-Fusion Spinal Deformity Correction in Adolescent Idiopathic Scoliosis - Mayo Clinic

   Any other medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the ...

2. A Study Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women with Type 1 Von Willebrand Disease - Mayo Clinic

   Willingness to make 4 visits, undergo blood sampling for coagulation studies, and accept randomization of two therapies for each of four consecutive menstrual ...

3. Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement - Mayo Clinic

   Disseminated intravascular coagulation; Intracranial hemorrhage. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

4. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders - Mayo Clinic

   Have an established Rare Coagulation Disorder (RCD) diagnosis of one of the following: 1. PAI-1 deficiency 2. Factor I, II, V, VII, X, XI, XIII deficiencies

5. Publications - Camille M. M. van Buskirk, M.D. - Mayo Clinic

   Coagulation profile of human COVID-19 convalescent plasma. Sci Rep. 2022 Jan 12; 12 (1):637. View PubMed; Senefeld JW, Johnson PW, Kunze KL, Bloch EM, van ...

6. A Study to Evaluate Stereotactic Radiosurgery Versus Hippocampal-Avoidant Whole Brain Radiotherapy for 10 or Fewer Brain Metastases from Small Cell Lung Cancer - Mayo Clinic

   Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects. Participating Mayo Clinic locations. Study statuses change often. Please ...

7. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

   > 2.5 mg/dL. Coagulation. International Normalized Ratio (INR) or Prothrombin Time (PT). ≤ 1.5 X ULN unless subject is receiving anticoagulant therapy as ...

8. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

   - Significant bleeding risk or coagulation disorders - History of gastrointestinal bleeding, e.g. in association with use of nonsteroidal anti-inflammatory ...

9. A Study to Evaluate Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant - Mayo Clinic

   INR ≤ 1.5 or correctable by Vitamin K, unless anti-coagulated for another medical reason. Bilirubin < 3.0 mg/dl (in the absence of obstruction or pre ...

10. Active Removal of IntraCerebral Hematoma Via Active Irrigation - Mayo Clinic

    If needed, normal coagulation profile (PT, PTT, platelet count) 7. Treatment within 72 hours of ictus 8. Ability to administer 2.0 mg of tPA per day for 3 ...